Search research articles
Contact Us
Filters
Showing results (91-100 of 113) with videos related to
Page
of 12
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 10, 2023
Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type
Andrew F Alexis, Jonathan I Silverberg, Zakiya P Rice, et al.
Journal of Drugs in Dermatology : JDD
|
February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice
Mark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
Dermatology and Therapy
|
July 22, 2025
Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials
Andrew F Alexis, Leon Kircik, Raj Chovatiya, et al.
American Journal of Clinical Dermatology
|
July 3, 2019
Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups
Valerie D Callender, Andrew F Alexis, Linda F Stein Gold, et al.
Journal of Dermatological Science
|
January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study
Andrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Journal of Drugs in Dermatology : JDD
|
December 4, 2024
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents
Lawrence F Eichenfield, Adelaide A Hebert, Julie C Harper, et al.
The Journal of Clinical and Aesthetic Dermatology
|
September 18, 2023
Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne
Jerry Tan, Zoe D Draelos, Melinda J Gooderham, et al.
The Journal of Dermatological Treatment
|
August 9, 2021
The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement
Daniel C Butler, Eric Simpson, Emma Guttman-Yassky, et al.
Dermatology and Therapy
|
October 2, 2024
A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis
Andrew F Alexis, Melinda Gooderham, Shawn G Kwatra, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
September 18, 2018
Atopic dermatitis in African American patients is T
Riana D Sanyal, Ana B Pavel, Jacob Glickman, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 113) with videos related to
Sort By:
Page
of 12
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 10, 2023
Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type
Andrew F Alexis, Jonathan I Silverberg, Zakiya P Rice, et al.
Journal of Drugs in Dermatology : JDD
|
February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice
Mark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
Dermatology and Therapy
|
July 22, 2025
Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials
Andrew F Alexis, Leon Kircik, Raj Chovatiya, et al.
American Journal of Clinical Dermatology
|
July 3, 2019
Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups
Valerie D Callender, Andrew F Alexis, Linda F Stein Gold, et al.
Journal of Dermatological Science
|
January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study
Andrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Journal of Drugs in Dermatology : JDD
|
December 4, 2024
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents
Lawrence F Eichenfield, Adelaide A Hebert, Julie C Harper, et al.
The Journal of Clinical and Aesthetic Dermatology
|
September 18, 2023
Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne
Jerry Tan, Zoe D Draelos, Melinda J Gooderham, et al.
The Journal of Dermatological Treatment
|
August 9, 2021
The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement
Daniel C Butler, Eric Simpson, Emma Guttman-Yassky, et al.
Dermatology and Therapy
|
October 2, 2024
A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis
Andrew F Alexis, Melinda Gooderham, Shawn G Kwatra, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
September 18, 2018
Atopic dermatitis in African American patients is T
Riana D Sanyal, Ana B Pavel, Jacob Glickman, et al.
Page
of 12